The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 27429068 |
54 |
Evolution of a Novel, Orally Bioavailable Series of PI3K? Inhibitors from an Inhaled Lead for the Treatment of Respiratory Disease. |
Glaxosmithkline R&D |
| 32298120 |
52 |
Discovery and Structure-Activity Relationship Study of ( |
Dana-Farber Cancer Institute |
| 32184968 |
36 |
Structure-Activity Relationship Study of Covalent Pan-phosphatidylinositol 5-Phosphate 4-Kinase Inhibitors. |
Dana-Farber Cancer Institute |
| 28526367 |
30 |
Discovery of a novel aminopyrazine series as selective PI3K? inhibitors. |
Astrazeneca |
| 28347666 |
45 |
Discovery of a series of 8-(1-phenylpyrrolidin-2-yl)-6-carboxamide-2-morpholino-4H-chromen-4-one as PI3K?/? inhibitors for the treatment of PTEN-deficient tumours. |
Astrazeneca |
Search and Browse
